The report will be delivered in 2-3 business days.

Pharmaceutical API Manufacturing Global Market Report 2021 - By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, NSAIDs, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Innovative Drugs, Generic Prescription, Over-The-Counter (OTC) Drugs), COVID-19 Growth And Change

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7094 | Format :


The pharmaceutical active pharmaceutical ingredients (API) manufacturing market consists of sales of pharmaceutical active pharmaceutical ingredients and related services. Active pharmaceutical ingredients are used to produce drugs which treat various diseases such as cardiovascular diseases, rare genetic disorders, infections, metabolic disorders, cancers, respiratory diseases and others. Active pharmaceutical ingredient is a chemical which is responsible for the pharmacological activity in the living body and are used as a major base for preparation of drugs.

The pharmaceutical API manufacturing market covered in this report is segmented by therapy area into cardiovascular disorders, metabolic disorders, neurological disorders, oncology, musculoskeletal disorders, NSAIDs, other therapeutics uses. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market is also segmented by API type into chemical API, biological API and by drug type into innovative drugs, generic prescription, over-the-counter (OTC) drugs.

The global pharmaceutical API manufacturing market is expected to grow from $170.06 billion in 2020 to $177.32 billion in 2021 at a compound annual growth rate (CAGR) of 4.3%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The pharmaceutical active pharmaceutical ingredients (API) manufacturing market is expected to reach $215.9 billion in 2025 at a CAGR of 5%.

The rise in aging population is one of the major drivers of the pharmaceutical API manufacturing market. As the aging population increases, the demand for pharmaceutical drugs also increases. API acts as a specialty drug in these medicines to cure a particular disease. For instance, in 2019, number of people over the age of 65 were 703 million, in 2050, the number of elderly people is expected to double to 1.5 billion. This led to increase demand for pharmaceutical drugs, significantly impacting the pharmaceutical API manufacturing market growth.

Stringent regulations for approval of pharmaceutical drugs acts as a restraint on the pharmaceutical API manufacturing market. Various regions have their own set of rules, guidelines, and regulations set by their respective drugs regulatory bodies. For example, in Japan, the manufacturers have to register an API with Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) through the country’s Drug Master File (DMF) system. Products like APIs and new excipients i.e. inactive substances used in a drug should be registered compulsorily. The API manufacturer is also responsible for DMF registration, even if they don't have their office in Japan. They should appoint an in-country caretaker (ICC) to apply on their behalf. Also, if there are any changes to be made to DMF products, either an application for change in registration or a minor change notification should be submitted by the ICC to the PMDA. This whole process delays the drugs approvals, thereby negatively affecting the pharmaceuticals API manufacturing market.

Many companies use modern technologies such as process control, and powder handling to optimize API manufacturing. These technologies include advances in Lyophilization i.e. freeze-drying process. It is a low-temperature dehydration process which involves freezing the product, lowering pressure and then removing the ice formed. For instance, Telstar, a company that manufactures efficient integrated systems for pharmaceutical and manufacturing processes, developed LyoGistics Zero, an automatic loading and unloading system for freeze dryers to manufacture hazardous products. The system uses a linear magnetic driving mechanism which functions without racks and belts to reduce particle generation and this improves the hygiene in API manufacturing. Also, ILC Dover, a pharmaceutical company, developed JetBreaker system, a semi-automatic powder handling system that separates powdered media and buffers powders so that they can be mixed better in a solution.

In January 2019, Bristol-Myers Squibb, a US-based company that discovers and manufactures biopharmaceutical products and drugs for cancer and other diseases acquired Celgene Corporation for $74 billion. With this acquisition, Bristol-Myers Squibb led to develop more innovative medicines and also result in a wider portfolio. Celgene Corporation, a US-based company that discovers, develops and commercializes medicines for cancer and inflammatory disorders.

Major players in the pharmaceutical active pharmaceutical ingredients (API) manufacturing market are Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Boehringer Ingelheim), Pfizer, Inc. and Aurobindo Pharma.

The regions covered in the pharmaceutical active pharmaceutical ingredients manufacturing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the pharmaceutical API manufacturing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global pharmaceutical API manufacturing market is segmented -

1) By Therapy Area: Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, NSAIDs, Other Therapeutics Uses

2) By API Type: Chemical API, Biological API

3) By Drug Type: Innovative Drugs, Generic Prescription, Over-The-Counter (OTC) Drugs

    Table Of Contents

    1. Executive Summary

    2. Pharmaceutical API Manufacturing Market Characteristics

    3. Pharmaceutical API Manufacturing Market Trends And Strategies

    4. Impact Of COVID-19 On Pharmaceutical API Manufacturing

    5. Pharmaceutical API Manufacturing Market Size And Growth

    5.1. Global Pharmaceutical API Manufacturing Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Pharmaceutical API Manufacturing Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Pharmaceutical API Manufacturing Market Segmentation

    6.1. Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Cardiovascular disorders

    Metabolic disorders

    Neurological disorders

    Oncology

    Musculoskeletal disorders

    NSAIDs

    Other therapeutics uses

    6.2. Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Chemical API

    Biological API

    6.3. Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Innovative Drugs

    Generic Prescription

    Over-the-counter (OTC) Drugs

    7. Pharmaceutical API Manufacturing Market Regional And Country Analysis

    7.1. Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Pharmaceutical API Manufacturing Market

    8.1. Asia-Pacific Pharmaceutical API Manufacturing Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Pharmaceutical API Manufacturing Market

    9.1. China Pharmaceutical API Manufacturing Market Overview

    9.2. China Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Pharmaceutical API Manufacturing Market

    10.1. India Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Pharmaceutical API Manufacturing Market

    11.1. Japan Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Pharmaceutical API Manufacturing Market

    12.1. Australia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Pharmaceutical API Manufacturing Market

    13.1. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Pharmaceutical API Manufacturing Market

    14.1. South Korea Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Pharmaceutical API Manufacturing Market

    15.1. Western Europe Pharmaceutical API Manufacturing Market Overview

    15.2. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Pharmaceutical API Manufacturing Market

    16.1. UK Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Pharmaceutical API Manufacturing Market

    17.1. Germany Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Pharmaceutical API Manufacturing Market

    18.4. France Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Pharmaceutical API Manufacturing Market

    19.1. Eastern Europe Pharmaceutical API Manufacturing Market Overview

    19.2. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Pharmaceutical API Manufacturing Market

    20.1. Russia Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Pharmaceutical API Manufacturing Market

    21.1. North America Pharmaceutical API Manufacturing Market Overview

    21.2. North America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Pharmaceutical API Manufacturing Market

    22.1. USA Pharmaceutical API Manufacturing Market Overview

    22.2. USA Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Pharmaceutical API Manufacturing Market

    23.1. South America Pharmaceutical API Manufacturing Market Overview

    23.2. South America Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Pharmaceutical API Manufacturing Market

    24.1. Brazil Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Pharmaceutical API Manufacturing Market

    25.1. Middle East Pharmaceutical API Manufacturing Market Overview

    25.2. Middle East Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Pharmaceutical API Manufacturing Market

    26.1. Africa Pharmaceutical API Manufacturing Market Overview

    26.2. Africa Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Pharmaceutical API Manufacturing Market Competitive Landscape And Company Profiles

    27.1. Pharmaceutical API Manufacturing Market Competitive Landscape

    27.2. Pharmaceutical API Manufacturing Market Company Profiles

    27.2.1. Teva Pharmaceutical Industries Ltd.

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Sun Pharmaceutical Industries Ltd.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Boehringer Ingelheim (Germany)

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Pfizer, Inc. (US)

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Aurobindo Pharma

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Pharmaceutical API Manufacturing Pipeline Analysis

    29. Key Mergers And Acquisitions In The Pharmaceutical API Manufacturing Market

    30. Pharmaceutical API Manufacturing Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: China, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: India, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: UK, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: France, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: North America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: USA, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: South America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Table 47: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Table 48: Boehringer Ingelheim (Germany) Financial Performance
  • Table 49: Pfizer, Inc. (US) Financial Performance
  • Table 50: Aurobindo Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Pharmaceutical API Manufacturing Market, Segmentation By Drug Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Pharmaceutical API Manufacturing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Pharmaceutical API Manufacturing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: China, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: India, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: Japan, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Australia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: UK, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: Germany, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: France, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Russia, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: North America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: USA, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: South America, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Africa, Pharmaceutical API Manufacturing Market, Segmentation By Therapy Area, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, Pharmaceutical API Manufacturing Market, Segmentation By API Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Teva Pharmaceutical Industries Ltd. Financial Performance
  • Figure 47: Sun Pharmaceutical Industries Ltd. Financial Performance
  • Figure 48: Boehringer Ingelheim (Germany) Financial Performance
  • Figure 49: Pfizer, Inc. (US) Financial Performance
  • Figure 50: Aurobindo Pharma Financial Performance
Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Generic Pharmaceuticals Global Market Report 2021 - By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Type (Biosimilar, Simple Generic, Super Generic), By Drug Delivery (Oral, Inectables, Dermal/Topical, Inhaler), COVID-19 Growth And Change
View Report
Antiemetics And Antinauseants Global Market Report 2021- By Drug (Dopamine Antagonists, NK1 Receptor Antagonist, Antihistamines (H1 Histamine Receptor Antagonists)), Cannabinoids, Benzodiazepines, Anticholinergics, Steroids, 5-HT3 Receptor Antagonists), By Application (Chemotherapy, Motion Sickness, Gastroenteritis, General Anaesthetics, Opioid Analgesics, Dizziness, Pregnancy, Food Poisoning, Emotional Stress), By End Users (Hospital, Medical Center, Clinic, Research Institutes), COVID-19 Impact and Recovery
View Report
Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Antifungals Global Market Report 2021 - By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), By End Users (Hospitals & Clinics, Dermatology Clinics), By Route of Administration (Oral, Parenteral, Topical), By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis), COVID-19 Impact and Recovery
View Report
Pharmaceutical Drugs And Biologics Logistics Market - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Diabetes Therapies Market - By Segments (Injectables And Oral), Trends, Key Players, Opportunities And Strategies – Global Forecast To 2023
View Report
Global Biologics Market - By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV or IP)), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2023
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)